Cagrilintide | |
Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. It is mainly used for the treatment of type 2 diabetes. It can lower blood sugar and control blood sugar levels. CAS No.: 1415456-99-3 EC Number: 206-141-6 | |
| Related Link: Click here to visit item owner's website (0 hit) | |
| Target State: All States Target City : All Cities Last Update : Jul 30, 2025 10:42 PM Number of Views: 22 | Item Owner : Anna Contact Email: Contact Phone: +86 19944061337 |
| Friendly reminder: Click here to read some tips. | |